| 0 |
MORBILLIVIRUS TEST POSITIVE |
1 |
0.2000 |
| 1 |
BREAST ANGIOSARCOMA METASTATIC |
1 |
0.1250 |
| 2 |
RUBIVIRUS TEST POSITIVE |
1 |
0.0625 |
| 3 |
VARICELLA MENINGITIS |
2 |
0.0400 |
| 4 |
RUBULAVIRUS TEST POSITIVE |
1 |
0.0385 |
| 5 |
GLUTAMATE DEHYDROGENASE INCREASED |
1 |
0.0090 |
| 6 |
PANCREATIC LEAK |
1 |
0.0089 |
| 7 |
ROSEOLOVIRUS TEST POSITIVE |
1 |
0.0082 |
| 8 |
HYPERADRENOCORTICISM |
2 |
0.0073 |
| 9 |
EAR, NOSE AND THROAT DISORDER |
1 |
0.0071 |
| 10 |
MYCOPLASMA TEST POSITIVE |
1 |
0.0066 |
| 11 |
PHARYNGEAL CANCER |
1 |
0.0056 |
| 12 |
ADRENOMEGALY |
1 |
0.0048 |
| 13 |
CARDIAC SEPTAL HYPERTROPHY |
1 |
0.0036 |
| 14 |
SALIVARY GLAND NEOPLASM |
1 |
0.0035 |
| 15 |
HYPERTENSIVE ENCEPHALOPATHY |
2 |
0.0034 |
| 16 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 17 |
VASCULAR STENOSIS |
1 |
0.0029 |
| 18 |
CHYLOTHORAX |
2 |
0.0028 |
| 19 |
ANAESTHESIA |
1 |
0.0027 |
| 20 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
1 |
0.0026 |
| 21 |
NON-SMALL CELL LUNG CANCER METASTATIC |
2 |
0.0023 |
| 22 |
CEREBRAL MICROHAEMORRHAGE |
1 |
0.0022 |
| 23 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 24 |
ADRENAL HAEMORRHAGE |
1 |
0.0018 |
| 25 |
RADIATION NECROSIS |
1 |
0.0017 |
| 26 |
HEAD AND NECK CANCER |
1 |
0.0015 |
| 27 |
MYASTHENIC SYNDROME |
1 |
0.0013 |
| 28 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 29 |
MEAN PLATELET VOLUME DECREASED |
1 |
0.0012 |
| 30 |
ATONIC SEIZURES |
1 |
0.0012 |
| 31 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 32 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 33 |
SARCOMA |
1 |
0.0009 |
| 34 |
METASTASES TO MENINGES |
2 |
0.0009 |
| 35 |
COLON OPERATION |
1 |
0.0008 |
| 36 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 37 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 38 |
PRODUCT STORAGE ISSUE |
3 |
0.0008 |
| 39 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 40 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 41 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 42 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 43 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 44 |
NON-SMALL CELL LUNG CANCER |
3 |
0.0006 |
| 45 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 46 |
MALIGNANT PLEURAL EFFUSION |
1 |
0.0006 |
| 47 |
ATAXIA |
7 |
0.0006 |
| 48 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 49 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 50 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 51 |
BLADDER SPASM |
1 |
0.0005 |
| 52 |
HYPOGEUSIA |
1 |
0.0005 |
| 53 |
CELL DEATH |
1 |
0.0005 |
| 54 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 55 |
RENAL FUNCTION TEST ABNORMAL |
2 |
0.0004 |
| 56 |
URINARY HESITATION |
1 |
0.0004 |
| 57 |
SUFFOCATION FEELING |
1 |
0.0004 |
| 58 |
MOTOR DYSFUNCTION |
4 |
0.0004 |
| 59 |
CHONDROPATHY |
1 |
0.0004 |
| 60 |
HYPERAESTHESIA |
3 |
0.0004 |
| 61 |
NEUROLOGICAL SYMPTOM |
2 |
0.0003 |
| 62 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 63 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 64 |
TASTE DISORDER |
7 |
0.0003 |
| 65 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 66 |
LUNG ADENOCARCINOMA |
1 |
0.0003 |
| 67 |
HYPERCAPNIA |
1 |
0.0003 |
| 68 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 69 |
SWELLING OF EYELID |
2 |
0.0003 |
| 70 |
ORTHOPNOEA |
1 |
0.0003 |
| 71 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 72 |
SKIN EROSION |
1 |
0.0003 |
| 73 |
HEPATIC CYST |
1 |
0.0003 |
| 74 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 75 |
SENSITIVE SKIN |
2 |
0.0003 |
| 76 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 77 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 78 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 79 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 80 |
SKIN ABRASION |
1 |
0.0002 |
| 81 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 82 |
ATELECTASIS |
2 |
0.0002 |
| 83 |
HYPOAESTHESIA ORAL |
3 |
0.0002 |
| 84 |
ERYSIPELAS |
1 |
0.0002 |
| 85 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 86 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 87 |
NEUROPATHY PERIPHERAL |
18 |
0.0002 |
| 88 |
SUDDEN DEATH |
2 |
0.0002 |
| 89 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 90 |
STRESS FRACTURE |
1 |
0.0002 |
| 91 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 92 |
JAW DISORDER |
1 |
0.0002 |
| 93 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 94 |
HYPERKERATOSIS |
1 |
0.0002 |
| 95 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 96 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 97 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 98 |
NEUROTOXICITY |
3 |
0.0002 |
| 99 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 100 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 101 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 102 |
DRUG RESISTANCE |
4 |
0.0002 |
| 103 |
GAIT INABILITY |
5 |
0.0001 |
| 104 |
TREATMENT NONCOMPLIANCE |
8 |
0.0001 |
| 105 |
JOINT EFFUSION |
1 |
0.0001 |
| 106 |
ENCEPHALITIS |
1 |
0.0001 |
| 107 |
PULMONARY ARTERIAL HYPERTENSION |
2 |
0.0001 |
| 108 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 109 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 110 |
TROPONIN INCREASED |
1 |
0.0001 |
| 111 |
ADVERSE EVENT |
12 |
0.0001 |
| 112 |
NERVOUS SYSTEM DISORDER |
4 |
0.0001 |
| 113 |
BRAIN FOG |
2 |
0.0001 |
| 114 |
RENAL CYST |
1 |
0.0001 |
| 115 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 116 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 117 |
HEMIPLEGIA |
1 |
0.0001 |
| 118 |
MYOPATHY |
1 |
0.0001 |
| 119 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 120 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 121 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 122 |
SPINAL DISORDER |
1 |
0.0001 |
| 123 |
BALANCE DISORDER |
9 |
0.0001 |
| 124 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 125 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 126 |
THERAPY CHANGE |
1 |
0.0001 |
| 127 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 128 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 129 |
MUSCULAR WEAKNESS |
11 |
0.0001 |
| 130 |
PULMONARY EMBOLISM |
9 |
0.0001 |
| 131 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 132 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 133 |
NERVE INJURY |
1 |
0.0001 |
| 134 |
MALNUTRITION |
1 |
0.0001 |
| 135 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 136 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 137 |
DIZZINESS |
44 |
0.0001 |
| 138 |
SCAB |
1 |
0.0001 |
| 139 |
MYOCARDITIS |
1 |
0.0001 |
| 140 |
NEURALGIA |
2 |
0.0001 |
| 141 |
CYTOPENIA |
1 |
0.0001 |
| 142 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 143 |
SPINAL OPERATION |
1 |
0.0001 |
| 144 |
DYSGEUSIA |
6 |
0.0001 |
| 145 |
AGEUSIA |
2 |
0.0001 |
| 146 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 147 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 148 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 149 |
HAND DEFORMITY |
1 |
0.0001 |
| 150 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 151 |
PNEUMONITIS |
2 |
0.0001 |
| 152 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 153 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 154 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 155 |
DYSSTASIA |
2 |
0.0001 |
| 156 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 157 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 158 |
BONE LOSS |
1 |
0.0001 |
| 159 |
DELUSION |
1 |
0.0001 |
| 160 |
PARAESTHESIA |
10 |
0.0001 |
| 161 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 162 |
DYSPHAGIA |
6 |
0.0001 |
| 163 |
PNEUMOTHORAX |
1 |
0.0001 |
| 164 |
MALIGNANT NEOPLASM PROGRESSION |
6 |
0.0001 |
| 165 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 166 |
DELIRIUM |
2 |
0.0001 |
| 167 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 168 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 169 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 170 |
OSTEOMYELITIS |
1 |
0.0001 |
| 171 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 172 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 173 |
HOSPITALISATION |
8 |
0.0001 |
| 174 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 175 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 176 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 177 |
FEEDING DISORDER |
1 |
0.0000 |
| 178 |
VERTIGO |
3 |
0.0000 |
| 179 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 180 |
GAIT DISTURBANCE |
9 |
0.0000 |
| 181 |
EATING DISORDER |
1 |
0.0000 |
| 182 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 183 |
HEPATOTOXICITY |
1 |
0.0000 |
| 184 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 185 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 186 |
SEIZURE |
5 |
0.0000 |
| 187 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 188 |
ANAEMIA |
8 |
0.0000 |
| 189 |
MYALGIA |
7 |
0.0000 |
| 190 |
LIVER INJURY |
1 |
0.0000 |
| 191 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 192 |
HALLUCINATION |
3 |
0.0000 |
| 193 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 194 |
SKIN ULCER |
1 |
0.0000 |
| 195 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 196 |
SPEECH DISORDER |
2 |
0.0000 |
| 197 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 198 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 199 |
PAIN OF SKIN |
1 |
0.0000 |
| 200 |
CONSTIPATION |
8 |
0.0000 |
| 201 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 202 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 203 |
FEELING COLD |
1 |
0.0000 |
| 204 |
NECK PAIN |
2 |
0.0000 |
| 205 |
DEMENTIA |
1 |
0.0000 |
| 206 |
WOUND |
1 |
0.0000 |
| 207 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 208 |
PAIN IN JAW |
1 |
0.0000 |
| 209 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 210 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 211 |
ASCITES |
1 |
0.0000 |
| 212 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 213 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 214 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 215 |
EPILEPSY |
1 |
0.0000 |
| 216 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 217 |
DEATH |
28 |
0.0000 |
| 218 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 219 |
FEMUR FRACTURE |
1 |
0.0000 |
| 220 |
IMPAIRED HEALING |
1 |
0.0000 |
| 221 |
OSTEONECROSIS |
1 |
0.0000 |
| 222 |
SKIN DISORDER |
1 |
0.0000 |
| 223 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 224 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 225 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 226 |
HYPOXIA |
1 |
0.0000 |
| 227 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 228 |
MOBILITY DECREASED |
2 |
0.0000 |
| 229 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 230 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 231 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 232 |
NAUSEA |
21 |
0.0000 |
| 233 |
ACNE |
2 |
0.0000 |
| 234 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 235 |
DISORIENTATION |
1 |
0.0000 |
| 236 |
CARDIAC FAILURE |
2 |
0.0000 |
| 237 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 238 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 239 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 240 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 241 |
MENTAL DISORDER |
1 |
0.0000 |
| 242 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 243 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 244 |
TINNITUS |
1 |
0.0000 |
| 245 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 246 |
OFF LABEL USE |
19 |
0.0000 |
| 247 |
RENAL DISORDER |
1 |
0.0000 |
| 248 |
SWELLING |
2 |
0.0000 |
| 249 |
COMA |
1 |
0.0000 |
| 250 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 251 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 252 |
HYPOAESTHESIA |
3 |
0.0000 |
| 253 |
LEUKOPENIA |
1 |
0.0000 |
| 254 |
SOMNOLENCE |
4 |
0.0000 |
| 255 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 256 |
FLUID RETENTION |
1 |
0.0000 |
| 257 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 258 |
PAIN |
12 |
0.0000 |
| 259 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 260 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 261 |
ILLNESS |
2 |
0.0000 |
| 262 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 263 |
NERVOUSNESS |
1 |
0.0000 |
| 264 |
DRUG INTERACTION |
3 |
0.0000 |
| 265 |
BRADYCARDIA |
1 |
0.0000 |
| 266 |
RASH PRURITIC |
1 |
0.0000 |
| 267 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 268 |
FALL |
6 |
0.0000 |
| 269 |
ARTHROPATHY |
1 |
0.0000 |
| 270 |
WEIGHT INCREASED |
4 |
0.0000 |
| 271 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 272 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 273 |
BONE PAIN |
1 |
0.0000 |
| 274 |
FATIGUE |
13 |
0.0000 |
| 275 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 276 |
PNEUMONIA |
5 |
0.0000 |
| 277 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 278 |
SWELLING FACE |
1 |
0.0000 |
| 279 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 280 |
RENAL FAILURE |
2 |
0.0000 |
| 281 |
DRY SKIN |
2 |
0.0000 |
| 282 |
HYPOTENSION |
3 |
0.0000 |
| 283 |
VOMITING |
7 |
0.0000 |
| 284 |
VISION BLURRED |
2 |
0.0000 |
| 285 |
ARTHRALGIA |
6 |
0.0000 |
| 286 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 287 |
DIARRHOEA |
9 |
0.0000 |
| 288 |
INFECTION |
2 |
0.0000 |
| 289 |
RASH |
6 |
0.0000 |
| 290 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 291 |
AGITATION |
1 |
0.0000 |
| 292 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 293 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 294 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 295 |
ARTHRITIS |
1 |
0.0000 |
| 296 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 297 |
THROMBOSIS |
1 |
0.0000 |
| 298 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 299 |
DYSPNOEA |
7 |
0.0000 |
| 300 |
DRY MOUTH |
1 |
0.0000 |
| 301 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 302 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 303 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 304 |
MIGRAINE |
1 |
0.0000 |
| 305 |
SYNCOPE |
1 |
0.0000 |
| 306 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 307 |
HEADACHE |
6 |
0.0000 |
| 308 |
HAEMORRHAGE |
1 |
0.0000 |
| 309 |
HYPERTENSION |
2 |
0.0000 |
| 310 |
MALAISE |
4 |
0.0000 |
| 311 |
INFLUENZA |
1 |
0.0000 |
| 312 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 313 |
DECREASED APPETITE |
2 |
0.0000 |
| 314 |
FEELING ABNORMAL |
2 |
0.0000 |
| 315 |
JOINT SWELLING |
1 |
0.0000 |
| 316 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 317 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 318 |
ASTHENIA |
3 |
0.0000 |
| 319 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 320 |
HYPERHIDROSIS |
1 |
0.0000 |
| 321 |
DEHYDRATION |
1 |
0.0000 |
| 322 |
NEUTROPENIA |
1 |
0.0000 |
| 323 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 324 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 325 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 326 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 327 |
COVID-19 |
1 |
0.0000 |
| 328 |
MUSCLE SPASMS |
1 |
0.0000 |
| 329 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 330 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 331 |
ALOPECIA |
1 |
0.0000 |
| 332 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 333 |
OVERDOSE |
1 |
0.0000 |
| 334 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 335 |
BACK PAIN |
1 |
0.0000 |
| 336 |
INSOMNIA |
1 |
0.0000 |
| 337 |
COUGH |
1 |
0.0000 |
| 338 |
ANXIETY |
1 |
0.0000 |
| 339 |
PYREXIA |
1 |
0.0000 |
| 340 |
PRURITUS |
1 |
0.0000 |